Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
February 06, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announced it has signed a...
Nanomaterials Market to Raise Income Levels to US$27.4 Billion By 2030, According to Persistence Market Research
January 11, 2024 11:45 ET
|
Persistence Market Research
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview: The nanomaterials market has experienced remarkable growth and diversification in recent years, driven by advancements in...
Nanomedicine Market Valuation to Reach USD 358 Billion by 2032 | Amid Rising Demand for Advanced Medical Solutions and Precision Healthcare
December 12, 2023 10:06 ET
|
Market.Us
New York, Dec. 12, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global nanomedicine market reached a value of USD 153 billion in 2023 and is projected to witness substantial growth,...
Dyadic to Present at Industry and Investor Events in October
September 29, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic to Present at Industry and Investor Events in October
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
July 13, 2023 04:00 ET
|
SiSaf Ltd
GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I....
Global Silver Nanoparticles Market Size To Worth $7.73 Billion By 2030 | CAGR of 15%
February 20, 2023 06:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Feb. 20, 2023 (GLOBE NEWSWIRE) -- The Global Silver Nanoparticles Market Size to grow from USD 2.20 billion in 2021 to USD 7.73 billion by 2030, at a Compound Annual Growth...
Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential
October 04, 2022 08:45 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Updates Market on Recent Scientific Achievements
September 13, 2022 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Nanoparticle Titanium Dioxide Market Size to Reach $17.3 Billion by 2030 | CAGR: 6.1%: AMR
July 27, 2021 09:00 ET
|
Allied Market Research
Portland, OR, July 27, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global nanoparticle titanium dioxide market was pegged at $9.7 billion in 2020, and is...
Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma
June 21, 2021 08:30 ET
|
Auris Medical AG
Treatment with OligoPhoreTM siRNA stops aggressive ATLL tumor growth to near zeroSignificant reduction in tumor size, spleen size and peripheral blood lymphocyte countsResults add to extensive body of...